CorePharma, founded in 1998, is a developer, manufacturer and marketer of high-quality, targeted, generic prescription pharmaceuticals across a variety of dosage forms and therapeutic categories. We specialize in difficult-to-develop high value products across a variety of therapeutic areas and currently produce almost one-half billion tablets and capsules annually. Our expertise in product development and manufacturing is complemented by robust sales, marketing and distribution capabilities.

CorePharma actively seeks partnerships, licensing and acquisition opportunities to complement and expand our product portfolio. By collaborating with innovative and trusted partners, we maximize the value of the relationship for all parties.

Impax Laboratories, Inc. completed the acquisition of CorePharma, aspiring to be a world class integrated specialty pharmaceutical company that builds on our collective strengths to create value for our customers, patients and shareholders.

For more information, go to


adidas eqt   | adidas eqt 9317   | adidas eqt adv   | adidas eqt adv 9317   | adidas eqt adv pk   | eqt adv shoes   | eqt adv 93   | eqt adv 9317   | eqt adv black green   | eqt adv pk   |